Belpointe Asset Management LLC Buys New Holdings in SPDR S&P Biotech ETF $XBI

Belpointe Asset Management LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 6,993 shares of the exchange traded fund’s stock, valued at approximately $701,000.

Other hedge funds have also bought and sold shares of the company. AQR Capital Management LLC raised its position in shares of SPDR S&P Biotech ETF by 77.1% in the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after buying an additional 2,167 shares in the last quarter. Ping Capital Management Inc. raised its position in shares of SPDR S&P Biotech ETF by 5.3% during the second quarter. Ping Capital Management Inc. now owns 6,000 shares of the exchange traded fund’s stock worth $498,000 after acquiring an additional 300 shares during the last quarter. DHJJ Financial Advisors Ltd. bought a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth about $25,000. Vanderbilt University acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at about $13,165,000. Finally, Washington Growth Strategies LLC grew its stake in SPDR S&P Biotech ETF by 14,117.3% during the second quarter. Washington Growth Strategies LLC now owns 11,516 shares of the exchange traded fund’s stock worth $955,000 after purchasing an additional 11,435 shares during the period.

SPDR S&P Biotech ETF Stock Down 1.6%

NYSEARCA:XBI opened at $124.75 on Friday. The firm has a market capitalization of $8.45 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $132.09. The company has a fifty day moving average of $123.78 and a 200-day moving average of $107.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.